Selinexor in Combination With HAD or CAG Rregimens in Relapsed or Refractory Acute Myeloid Leukemia
Clinical trial NCT05726110 · RECRUITING
Trial details
- NCT number
- NCT05726110
- Sponsor
- Shanxi Bethune Hospital
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-29
- Primary completion
- 2024-12-10
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.